Travere Therapeutics (TVTX) Current Assets (2012 - 2026)
Travere Therapeutics' Current Assets came in at $615.14 million for Q2 2026, up 62.1% from $379.57 million a year earlier and up 56.7% from the prior quarter.
Travere Therapeutics (TVTX) Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics' Current Assets was $437.57 million, up 5.0% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Going back by year, Current Assets was $416.7 million in FY2024 (-32.4%), $616.78 million in FY2023 (+26.8%), $486.44 million in FY2022 (-16.5%) and $582.83 million in FY2021 (+42.0%).
- The Q2 2026 figure represents the highest quarterly Current Assets since Q4 2023.
- Year-over-year, Current Assets has increased for five consecutive quarters, with an average decline of 2.3% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q2 2026 (growth of 62.1%), and the weakest in Q3 2024 (a decline of 52.7%).
- Business Quant data shows TVTX's Current Assets at $392.68 million (Q1 2026), $437.57 million (Q4 2025) and $371.11 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Travere Therapeutics | 4.93 Bn | 4.53 Bn | 167.41 Mn | 615.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 615.14 Mn |
| Mar 31, 2026 | 392.68 Mn |
| Dec 31, 2025 | 437.57 Mn |
| Sep 30, 2025 | 371.11 Mn |
| Jun 30, 2025 | 379.57 Mn |
| Mar 31, 2025 | 374.17 Mn |
| Dec 31, 2024 | 416.70 Mn |
| Sep 30, 2024 | 324.74 Mn |
| Jun 30, 2024 | 368.98 Mn |
| Mar 31, 2024 | 481.08 Mn |
| Dec 31, 2023 | 616.78 Mn |
| Sep 30, 2023 | 686.23 Mn |
| Jun 30, 2023 | 542.06 Mn |
| Mar 31, 2023 | 604.90 Mn |
| Dec 31, 2022 | 486.44 Mn |
| Sep 30, 2022 | 534.84 Mn |
| Jun 30, 2022 | 586.78 Mn |
| Mar 31, 2022 | 631.09 Mn |
| Dec 31, 2021 | 582.83 Mn |
| Sep 30, 2021 | 579.08 Mn |
Travere Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();